Wayne State University
Detroit, Michigan, 48201, United States
NCT Number: NCT04091464
Individuals with multiple sclerosis (MS) experience in impairments in mobility and cognition that increase the risk for accidental falls. More than 50% of individuals with MS experience injurious falls within a 6-month period. Current interventions to improve fall risk have focused on forward walking (FW) and balance training, resulting in small declines in the relative risk for falls with a large degree of variability. Interestingly, motor differences between MS and healthy controls are more pronounced in backward walking (BW), yet no studies have investigated BW training as an intervention to reduce fall risk in persons with MS. This study will investigate the feasibility, acceptability and impact of BW training compared to forward walking training on motor function and fall risk in persons with MS.
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Interventional
Not applicable
Detroit, Michigan, 48201, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Training will consist of BW training on both a treadmill and overground. All participants will receive 1x/week training with a trained member of the research team, who will progress the participant week-to-week and ensure safety. Treadmill speed will be determined by baseline BW walking speed and incrementally increased with each training week to subject tolerance. Participants will follow a home exercise program for the remainder of the week that includes BW, backward stepping, and functional exercises that incorporate BW movements.
Training will consist of FW training on both treadmill and overground. All participants will receive 1x/week training with a trained member of the research team, who will progress the participant week-to-week and ensure safety. Treadmill speed will be determined by baseline FW walking speed and incrementally increased with each training week to subject tolerance. Participants will follow a home exercise program for the remainder of the week that includes FW, forward stepping, and functional exercises that incorporate FW movements.
Time frame: Change in sway at 8 weeks
Measured with APDM Sensors
Time frame: Change in stepping latency at 8 weeks
Measured with APDM Sensors
Time frame: 8 weeks
Scores range from 8-32, with high scores indicating greater satisfaction with the intervention
Time frame: 8 weeks
Perceived Treatment Effect; scores range from 1-7 with higher scores indicating greater perception of improvement related to the intervention.
Time frame: Change in Physical Activity measures at 8 weeks
Measured with Accelerometry, passively collected for a 1 week period prior to the intervention and again after the intervention concludes 8 weeks later.
Time frame: 6 months
Number of falls reported in 6 month period after the intervention ends
Time frame: Change in velocity and double support time at 8 weeks
Walking speed and double support time (spatiotemporal measures of gait)
Time frame: Change in balance confidence at 8 weeks
Balance confidence
Wayne State University
Other
Acronym: TRAIN-BW
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07630311
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Ioannina, Greece
View Trial DetailsNCT06615947
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Barcelona, Spain
View Trial DetailsNCT04292717
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Zurich, Switzerland
View Trial DetailsNCT04855825
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
West Orange, New Jersey, United States
View Trial Details